Navigation Links
Parkway Clinical Laboratories Expands Management Team to Support a National Growth Strategy Centered on Oral Fluid Drug Screening
Date:1/7/2008

BENSALEM, Pa., Jan. 7 /PRNewswire/ -- Parkway Clinical Laboratories (http://www.parkwayclinical.com), a national, full-service, CLIA-certified clinical reference laboratory located in Bensalem, Pa., has expanded its management team by naming Mats Sanden, M.D., as medical director, Masood Haider, Ph.D., as vice president of Operations, Carolyn Bonner as director of Business Development and John Carson as director of Sales.

"We begin the New Year with a resolve to rapidly grow our various service offerings. I am particularly excited about our Intercept oral fluid employee substance abuse testing service and comfortably see us establishing a national footprint in this area in a very short period of time. We are assembling a very competent team that is not only diverse but a pleasure to work with," said Dr. Raza Bokhari, chairman and CEO, Parkway Clinical Laboratories.

Drs. Sanden and Haider are devoted to operational excellence and securing highest accreditation and certifications.

Carolyn Bonner is leading the national growth plan for the oral fluid employee drug screening service using the Orasure Intercept collection device and testing methodology, targeting local, regional, national and international corporations.

John Carson is focused on increasing a concentrated regional presence as a full service clinical reference laboratory for medical practitioners and veterinarians as well as strengthening existing relations in the mental and behavioral health market segment.

About Parkway Clinical Laboratories

Parkway Clinical Laboratories (PCL) is an emerging national CLIA-certified clinical reference laboratory performing routine and esoteric diagnostic testing with a focus on oral fluid substance of abuse screening in workplace environments (settings or arenas). Conveniently located in Bensalem, Pa., our primary facility is situated in the northeast subu
'/>"/>

SOURCE Parkway Clinical Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Philadelphia Insurance Companies to Sponsor the 2007 Parkway Run/Walk
2. Ardea Biosciences Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
3. ADA Issues New Clinical Practice Recommendations
4. Immtech Announces Pafuramidine (DB289) Program on Clinical Hold
5. Menopausal Women May Have an Increased Asthma Risk, From The Journal of Allergy and Clinical Immunology
6. New Book Looks at Clinical Research from the Patients Point of View
7. Xeloda(R), Taxotere(R) and Herceptin(R) Combination Study Suggests Clinical Benefit in Invasive Breast Cancer with Shortened Treatment Cycle
8. QRxPharma Initiates Second Phase III Clinical Trial for its Dual Opioid Pain Therapy
9. Advanced Clinical Research Services Enhances Biostatistics Offering
10. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
11. Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...ation,s Job Creators ,, WASHINGTON, Nov. 8 /PRN...assage of the health care bill (H.R. 3962), Small ...il) president & CEO Karen Kerrigan issued the ...e voting for H.R. 3962 voted to burden our nation,...s and penalties. Even in the best of economic time...
(Date:11/8/2009)...uot;Preventing and Healing AIDS Through Our Inner ...IDS is a result of multiple, repeated and chronic ...tressor agents, which can be either chemical, phys... Oakland, CA (PRWEB) Novemb...ologists, physicians, chemists and other scientist...
(Date:11/8/2009)... Network (MHN) urges military veterans to learn ab... exposure to chemicals, atomic agents and soot or ... of those cancers that is two times more prevalent...currently smoke cigarettes. , ...’s Health Network (MHN) kicked-off their Vet...
(Date:11/8/2009)... is won," said Dr. Charmaine Yoest. ,, WASHING...f 240-194, the Stupak-Ellsworth-Pitts-Kaptur-Dahlk...n mandates and funding in HR 3962 passed on the Ho...President and CEO Dr. Charmaine Yoest said, "The p...life Americans across this country who have floode...
(Date:11/8/2009)...ire/ -- Pharmaceutical Research and Manufacturers ...on released the following statement regarding the ...pointed, but not surprised by today,s vote -- an u...ans as well as nearly half of the members of the U... bill. ,, "While well intentioned, the bill -- ...
Breaking Medicine News(10 mins):Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3
...ism and related advocacy groups are questioning th...providing a strategy for laying out// treatment re...Clement, in response has released a series of smal...and a Families for Early Autism Treatment advocacy...
...Technology, Jadavpur University, Kolkata and Depar...llege, Andhra Pradesh done a// study on Plumeria A...y was to evaluate the anti-inflammatory activity o.... Plumeria Acuminata belongs to the family o...
...loped at Singapore's National University Hospital ...said Saturday.// The hospital is conducting a ...ing treatment after the "optical biopsy" diagnosed...y cells. Pap smears, the usual method used to ...
...but to have a long life, one needs to make a consc...p bad habits.// A study tracked more than 5,8...e age was 54. The finding revealed that the chance...ad only a 22% chance of living till they were 85 y...
...dren may have sleep problems that regular physical... Research published in the November issue of ...t, inactive children tested positive for sleep-dis...ball and tag games, the number of children who tes...
... Board Hospital is experiencing a dearth of specia... manager, Sue Capenerhurst.// Mrs. Capenerhu...p with the shortfall in obstetricians till end-Dec...the crisis. The medical board is also in ...
Other Medicine News:Health News:Anti Inflammatory Evaluation Of Plumeria Acuminata Leaves 2Health News:Sleep Problems in Overweight Children Appear Fairly Common 2Health News:Sleep Problems in Overweight Children Appear Fairly Common 3
(Date:11/6/2009).... 6 SCOLR Pharma, Inc. (...the three and nine months ended September 30, 2009...ent and CEO, said, "We continue to advance discuss...rmulation. Several potential partners have committ...ternal resources as they evaluate the potential co...
(Date:11/6/2009)...PRNewswire/ -- Trius Therapeutics, Inc. announced ...n Form S-1 with the U.S. Securities and Exchange C...lic offering of shares of its common stock. All sh...g will be offered by the Company. ,, Credit Sui...nning manager, Piper Jaffray & Co. is acting a...
(Date:11/6/2009)...Newswire-FirstCall/ -- Caraco Pharmaceutical Labor...rolac tromethamine ophthalmic solution, 0.5% follo...ministration (FDA) for Sun Pharma,s Abbreviated Ne... ophthalmic solution on the first day following pa...rapeutically equivalent to Acular® Ophthalmic...
Breaking Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Siblings target of intervention program 50533 1Both good bad movie characters who smoke influence teens to do the same 50531 1Both good bad movie characters who smoke influence teens to do the same 50531 2Colorectal cancer 9090 1
Plus Cylinders only Trial Lens Set
Magnetic LAnthony 15 desaturated Kit (4 lbs)
Opti-Free Express No Rub
Grafton Trial Frame
Medicine Products: